Tutorials › Pharmacokinetic-Pharmacodynamic (PK/PD) Modeling › Mixed Inhibition and Substrate-Dependent Parameter Interpretation

Mechanism-Based Inhibition and Activation · Tutorial 273 of 598

Mixed Inhibition and Substrate-Dependent Parameter Interpretation

Learn how inhibitor binding to free enzyme and enzyme–substrate complex changes apparent \(K_m\), \(V_{\max}\), and the observed degree of inhibition.

Advanced 12 min read

What You'll Learn

  • Derive the mixed-inhibition rate equation from enzyme conservation and binding relationships.
  • Interpret the roles of \(\alpha\) and \(\alpha'\) in apparent \(K_m\) and \(V_{\max}\).
  • Distinguish competitive, uncompetitive, pure noncompetitive, and general mixed inhibition.
  • Calculate how the observed inhibition changes with substrate concentration.
  • Identify data and diagnostics needed to estimate mixed-inhibition parameters.
  • Avoid interpreting apparent \(K_m\) as a direct measure of substrate binding affinity.

Why Mixed Inhibition Depends on Substrate Concentration

An inhibitor may bind both free enzyme and the enzyme–substrate complex, but with different affinities. The resulting inhibition is called mixed inhibition. Because substrate and inhibitor binding affect different enzyme states, a single inhibitor concentration can produce different apparent effects at low and high substrate concentrations. Interpreting those effects requires keeping the apparent Michaelis constant separate from the maximum reaction rate.

The derivation below uses the Michaelis–Menten framework and the reversible competitive-binding idea developed in the earlier material on competitive inhibition. It considers initial reaction rates, before substantial substrate depletion or product accumulation. The inhibitor is assumed to bind reversibly; the inhibitor-bound forms are catalytically inactive; free substrate and inhibitor concentrations are effectively constant during the rate measurement; and the total enzyme concentration is conserved. Substrate occupancy is represented by the usual Michaelis–Menten steady-state relationship. Inhibitor binding to free enzyme and enzyme–substrate complex is treated as rapid relative to the rate measurement.

Definition: In mixed inhibition, inhibitor \(I\) can bind both free enzyme \(E\) and enzyme–substrate complex \(ES\). The two dissociation constants are \(K_i\) for \(E+I\rightleftharpoons EI\) and \(K_i'\) for \(ES+I\rightleftharpoons ESI\). The complexes \(EI\) and \(ESI\) are assumed not to form product. Define \(\alpha=1+[I]/K_i\) and \(\alpha'=1+[I]/K_i'\), where \([I]\) is the free inhibitor concentration.

The quantities \(K_i\) and \(K_i'\) describe inhibitor binding to different enzyme states, while \(\alpha\) and \(\alpha'\) summarize the corresponding effects at a specified free inhibitor concentration. The rate parameters without inhibitor are \(V_{\max}\), the maximum rate, and \(K_m\), the Michaelis constant. Under the stated assumptions, the inhibitor changes these into apparent parameters; they are not new intrinsic constants of the enzyme.

Deriving the Mixed-Inhibition Rate Equation

For the standard Michaelis–Menten mechanism, the steady-state substrate relationship is \([ES]=[E][S]/K_m\), where \([S]\) is free substrate concentration. Inhibitor binding gives \([EI]=[E][I]/K_i\) and \([ESI]=[ES][I]/K_i'\). Thus the total enzyme concentration \(E_T\), including all four enzyme forms, can be written as follows.

$$ \begin{aligned} E_T &=[E]+[EI]+[ES]+[ESI]\\ &=[E]\left(1+\frac{[I]}{K_i}\right) +[ES]\left(1+\frac{[I]}{K_i'}\right)\\ &=[E]\left(\alpha+\alpha'\frac{[S]}{K_m}\right). \end{aligned} $$

The rate is the product-forming flux from \(ES\), so \(v=k_{\mathrm{cat}}[ES]\). Since \(V_{\max}=k_{\mathrm{cat}}E_T\), substituting the enzyme balance into the rate expression gives the mixed-inhibition equation. The algebra also shows why the two binding effects appear in different parts of the denominator.

$$ \begin{aligned} v &=k_{\mathrm{cat}}[E]\frac{[S]}{K_m}\\ &=V_{\max} \frac{[S]/K_m}{\alpha+\alpha'[S]/K_m}\\ &=\frac{V_{\max}[S]}{\alpha K_m+\alpha'[S]}. \end{aligned} $$
Theorem: Under the stated mixed-inhibition assumptions, the rate has Michaelis–Menten form with apparent parameters \(K_{m,\mathrm{app}}=(\alpha/\alpha')K_m\) and \(V_{\max,\mathrm{app}}=V_{\max}/\alpha'\). Therefore, \(v=V_{\max,\mathrm{app}}[S]/(K_{m,\mathrm{app}}+[S])\).

At low substrate concentration, the rate is approximately \(V_{\max}[S]/(\alpha K_m)\), so binding to free enzyme, represented by \(\alpha\), strongly affects the initial slope. At very high substrate concentration, the rate approaches \(V_{\max}/\alpha'\), so binding to \(ES\), represented by \(\alpha'\), determines the limiting rate. These limits explain why substrate concentration changes the observed degree of inhibition.

How the Special Cases Differ

The general mixed model includes familiar inhibition patterns as restrictions on \(\alpha\) and \(\alpha'\). Here, “pure noncompetitive” means that the inhibitor binds free enzyme and enzyme–substrate complex equally at the specified inhibitor concentration, so \(\alpha=\alpha'\). General mixed inhibition does not require equal binding.

PatternFactor restriction\(K_{m,\mathrm{app}}\)\(V_{\max,\mathrm{app}}\)
Competitive\(\alpha>1,\ \alpha'=1\)Increases to \(\alpha K_m\)Unchanged
Uncompetitive\(\alpha=1,\ \alpha'>1\)Decreases to \(K_m/\alpha'\)Decreases to \(V_{\max}/\alpha'\)
Pure noncompetitive\(\alpha=\alpha'>1\)UnchangedDecreases to \(V_{\max}/\alpha'\)
General mixed\(\alpha>1,\ \alpha'>1,\ \alpha\ne\alpha'\)May increase or decreaseDecreases

For general mixed inhibition, \(K_{m,\mathrm{app}}\) increases when \(\alpha>\alpha'\), decreases when \(\alpha<\alpha'\), and remains unchanged when \(\alpha=\alpha'\). A change in apparent \(K_m\) is not, by itself, evidence that substrate binding affinity has changed. It is a property of the rate curve resulting from the combined effects of inhibitor binding and substrate turnover.

Worked Example: Calculate Apparent Parameters for Mixed Inhibition

Suppose a hypothetical enzyme has \(K_m=2.00\ \mathrm{mM}\) and \(V_{\max}=100\ \mathrm{nmol\,min^{-1}}\). At a free inhibitor concentration of \(4.00\ \mathrm{\mu M}\), let \(K_i=2.00\ \mathrm{\mu M}\) and \(K_i'=8.00\ \mathrm{\mu M}\). Calculate the apparent parameters and the rate at \([S]=4.00\ \mathrm{mM}\).

First calculate the binding factors:

$$ \alpha=1+\frac{4.00}{2.00}=3.00,\qquad \alpha'=1+\frac{4.00}{8.00}=1.50. $$

The apparent Michaelis constant and maximum rate are therefore

$$ K_{m,\mathrm{app}}=\frac{3.00}{1.50}(2.00\ \mathrm{mM}) =4.00\ \mathrm{mM}, \qquad V_{\max,\mathrm{app}}=\frac{100}{1.50} =66.7\ \mathrm{nmol\,min^{-1}}. $$

Using the mixed-inhibition rate equation at \(4.00\ \mathrm{mM}\) substrate gives

$$ v=\frac{(100\ \mathrm{nmol\,min^{-1}})(4.00\ \mathrm{mM})} {(3.00)(2.00\ \mathrm{mM})+(1.50)(4.00\ \mathrm{mM})} =\frac{400}{12.0} =33.3\ \mathrm{nmol\,min^{-1}}. $$

The apparent \(K_m\) is higher and the apparent \(V_{\max}\) is lower than their uninhibited values. This is general mixed inhibition with \(\alpha>\alpha'\), not pure noncompetitive inhibition.

Worked Example: Compare the Three Special Patterns

Consider hypothetical baseline values \(K_m=3.00\ \mathrm{mM}\) and \(V_{\max}=120\ \mathrm{nmol\,min^{-1}}\). Compare three inhibitor conditions represented by factors \((\alpha,\alpha')=(2,1)\) for competitive inhibition, \((1,2)\) for uncompetitive inhibition, and \((2,2)\) for pure noncompetitive inhibition. Find the apparent parameters and rates at \([S]=3.00\ \mathrm{mM}\).

For competitive inhibition, \(K_{m,\mathrm{app}}=(2/1)(3.00)=6.00\ \mathrm{mM}\) and \(V_{\max,\mathrm{app}}=120/1=120\ \mathrm{nmol\,min^{-1}}\). The rate is \(120(3.00)/(6.00+3.00)=40.0\ \mathrm{nmol\,min^{-1}}\).

For uncompetitive inhibition, \(K_{m,\mathrm{app}}=(1/2)(3.00)=1.50\ \mathrm{mM}\) and \(V_{\max,\mathrm{app}}=120/2=60.0\ \mathrm{nmol\,min^{-1}}\). The rate is \(60.0(3.00)/(1.50+3.00)=40.0\ \mathrm{nmol\,min^{-1}}\).

For pure noncompetitive inhibition, \(K_{m,\mathrm{app}}=(2/2)(3.00)=3.00\ \mathrm{mM}\) and \(V_{\max,\mathrm{app}}=120/2=60.0\ \mathrm{nmol\,min^{-1}}\). The rate is \(60.0(3.00)/(3.00+3.00)=30.0\ \mathrm{nmol\,min^{-1}}\).

Competitive and uncompetitive inhibition happen to give the same rate at this one substrate concentration, despite having different apparent parameters. A rate measured at a single \([S]\) cannot generally identify the inhibition pattern; the shape of the rate response across substrate concentrations is essential.

Interpreting Substrate-Dependent Inhibition

The ratio of inhibited to uninhibited rates at the same substrate concentration provides a direct measure of how the observed effect varies with substrate. Dividing the mixed-inhibition rate by the uninhibited Michaelis–Menten rate gives

$$ \frac{v_I}{v_0} =\frac{K_m+[S]}{\alpha K_m+\alpha'[S]}. $$

As \([S]\) approaches zero, this ratio approaches \(1/\alpha\). As \([S]\) becomes very large, it approaches \(1/\alpha'\). Thus, when \(\alpha>\alpha'\), increasing substrate reduces the fractional inhibition, but does not necessarily eliminate it: the high-substrate rate ratio approaches \(1/\alpha'\). When \(\alpha<\alpha'\), inhibition can become relatively stronger as substrate increases. These are comparisons at fixed free inhibitor concentration and under the model assumptions, not universal statements about every experimental system.

Worked Example: Quantify Inhibition at Low and High Substrate

Use the hypothetical values from the first example: \(K_m=2.00\ \mathrm{mM}\), \(V_{\max}=100\ \mathrm{nmol\,min^{-1}}\), \(\alpha=3.00\), and \(\alpha'=1.50\). Compare inhibited and uninhibited rates at \([S]=0.500\ \mathrm{mM}\) and \(20.0\ \mathrm{mM}\).

At \(0.500\ \mathrm{mM}\), the uninhibited rate is \(100(0.500)/(2.00+0.500)=20.0\ \mathrm{nmol\,min^{-1}}\). The inhibited rate is \(100(0.500)/(3.00(2.00)+1.50(0.500))=50.0/6.75=7.41\ \mathrm{nmol\,min^{-1}}\). The rate ratio is \(7.41/20.0=0.370\), corresponding to a 63.0% reduction.

At \(20.0\ \mathrm{mM}\), the uninhibited rate is \(100(20.0)/(2.00+20.0)=90.9\ \mathrm{nmol\,min^{-1}}\). The inhibited rate is \(100(20.0)/(3.00(2.00)+1.50(20.0))=2000/36.0=55.6\ \mathrm{nmol\,min^{-1}}\). The ratio is \(55.6/90.9=0.611\), a 38.9% reduction. At very high substrate, the ratio approaches \(1/1.50=0.667\), consistent with the calculated value being closer to that limit.

Estimation, Diagnostics, and Limits

To distinguish the mechanisms, rate data need to cover substrate concentrations both below and above the relevant \(K_m\), preferably at several inhibitor concentrations and with an uninhibited control. Low-substrate observations help characterize the \(\alpha K_m\) term; high-substrate observations help characterize \(V_{\max}/\alpha'\). If all measurements are at low substrate, the data may provide little information about \(\alpha'\). If all are at high substrate, they may provide little information about \(\alpha K_m\). The separate inhibitor-binding constants may also be poorly determined if the inhibitor concentrations do not span a range that meaningfully changes the factors.

In practice, fitting the rate equation directly to untransformed rates is generally preferable to relying on reciprocal plots. Reciprocal transformations can make measurement errors at low rates disproportionately influential. Fit the nested special cases as well as the general mixed model when they are scientifically plausible, and inspect residuals across substrate and inhibitor concentrations. Systematic curvature or a pattern that changes with inhibitor concentration can signal a poor fit, but does not uniquely identify its cause. Check whether rates were measured in the initial-rate range, whether free concentrations are reasonably approximated by the stated concentrations, and whether the assumed inactive inhibitor complexes and simple reversible binding are defensible.

The model has important limits. It does not describe time-dependent changes in enzyme activity, inhibitor-induced activation, substrate depletion, or additional binding states. A good fit does not prove that the proposed binding mechanism is unique: different mechanisms can produce similar rate curves over a limited concentration range. Moreover, apparent \(K_m\) is a composite kinetic parameter, not necessarily the substrate dissociation constant. Mechanistic conclusions should therefore be supported by informative concentration ranges and relevant experimental controls.

Common pitfall: “The apparent \(K_m\) fell, so the inhibitor must have increased substrate affinity.” This conclusion is not justified by the rate equation. \(K_{m,\mathrm{app}}=(\alpha/\alpha')K_m\) can fall because inhibitor binding to \(ES\) is stronger relative to binding to free enzyme, even if the intrinsic substrate-binding properties have not changed. Interpret the apparent parameters as features of the inhibited rate curve, not as direct measurements of molecular affinity.

Check Your Understanding

Answer each question using the mixed-inhibition model; brief solutions follow.

  1. If \(\alpha=1\) and \(\alpha'=2\), what happens to apparent \(K_m\) and apparent \(V_{\max}\)?
  2. For \(\alpha=2\) and \(\alpha'=4\), does apparent \(K_m\) increase, decrease, or remain unchanged?
  3. What is the limiting ratio of inhibited to uninhibited rate as substrate concentration becomes very large?
  4. Why can one rate measurement at one substrate concentration fail to distinguish competitive from uncompetitive inhibition?

Solutions. (1) \(K_{m,\mathrm{app}}=K_m/2\), and \(V_{\max,\mathrm{app}}=V_{\max}/2\): uncompetitive inhibition. (2) The ratio \(\alpha/\alpha'=2/4=0.500\), so apparent \(K_m\) decreases to \(0.500K_m\). (3) The limit is \(1/\alpha'=1/4=0.250\). (4) Different inhibition patterns can yield the same rate at a particular substrate concentration, as the worked comparison demonstrates; measurements across a substrate range are needed to compare curve shapes and apparent parameters.

Clinical Biostats